A double-blind, placebo-controlled, randomizedwithdrawal study of lisdexamfetamine dimesylate in adults with moderate to severe binge eating disorder

Authors
Category Primary study
ConferenceCNS Spectrums
Year 2017
This article has no abstract
Epistemonikos ID: f3b9fa9db15f231ac900c119be3cb708eac7d8b3
First added on: Apr 29, 2026